Prophylactic Radiotherapy for the Prevention of Procedure-Tract Metastases in Malignant Pleural Mesothelioma

TAKE-HOME MESSAGE

This multicenter, open-label phase III study evaluated the utility of prophylactic radiation to prevent procedure-tract metastases in 203 patients with malignant pleural mesothelioma. No significant differences were observed in procedure-tract metastases incidence in those who received immediate radiotherapy vs those receiving deferred radiation therapy.

Routine universal prophylactic radiotherapy to prevent procedure-tract metastases in patients with malignant pleural mesothelioma offers no clear clinical benefit.

BACKGROUND

The use of prophylactic radiotherapy to prevent procedure-tract metastases (PTMs) in malignant pleural mesothelioma remains controversial, and clinical practice varies worldwide. We aimed to compare prophylactic radiotherapy with deferred radiotherapy (given only when a PTM developed) in a suitably powered trial.

[Article continues at original source]

Source: Prophylactic Radiotherapy for the Prevention of Procedure-Tract Metastases in Malignant Pleural Mesothelioma

 


 Mesothelioma, Asbestos, and Legal Compensation: Basic Facts

Asbestos-Mesothelioma Case Evaluation Form
Free.  Confidential.  No Obligation.

Speak Your Mind

*

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, NC 28403
Tel: (800) 426-9535
Email@LambLawOffice.com
Disclaimer and Copyright